Other Private Equity/Strategic Investments
Sun Pharma to acquire 26% in digital diagnostic devices maker Agatsa for Rs.30-Cr
Pharmaceutical company Sun Pharma has acquired a 26.09% stake in Noida-headquartered Agatsa Software Pvt Ltd, an early-stage digital diagnostic devices company, for INR 30 crore. The acquisition will be made in two tranches. Tranche 1 of INR 8 crore would be completed in February 2023 and Tranche 2 of INR 22 crore would be completed by August 2023. Agatsa, incorporated in 2010, is engaged in the research & development and commercialization of medical devices (starting with wearable health monitoring solution named Sanket) in the diagnostic health segment. The company's revenue from operations for 2021-22 was INR 44 lakh (down from INR 2.2 Cr in FY21). From the Venture Intelligence Angel Deal Database: Between Sep-15 and May-22, Agasta had raised angel funding from Sanjiv Bajaj, Priyank Agarwal, Indian Angel Network, Nikunj Jain, others.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
